Geron Corporation Names Harout Semerjian as New CEO to Lead Commercialization of RYTELO
Geron Corporation (NASDAQ:GERN) is one of the most promising penny stocks under $5.
Geron Corp (GERN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 60,379,366 | $85,134,906 | 1.43% | |
| 2. | Deep Track Capital David Kroin | 43,000,000 | $60,630,000 | +13% | 1.94% |
| 3. | Vivo Capital Albert Cha And Frank Kung | 27,225,292 | $38,387,662 | 3.93% | |
| 4. | Vestal Point Capital Ryan Wilder | 23,775,000 | $33,522,750 | +9% | 1.76% |
| 5. | Soleus Capital Guy Levy | 16,140,000 | $22,757,400 | +573% | 1.51% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.18 | 13,300 | $15,667.40 | 13,300 | 2025-05-09 | Filing | |
| $1.61 | 15,000 | $24,150.00 | 26,682 | 2025-02-27 | Filing | |
| $1.77 | 12,500 | $22,062.50 | 12,500 | 2025-02-27 | Filing | |
| $1.60 | 100,000 | $160,000.00 | 100,000 | 2025-02-27 | Filing | |
| $2.28 | 6,579 | $15,000.12 | 26,220 | 2023-08-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.56 | 674,348 | $3,073,003.84 | 0 | 2024-07-08 | Filing | |
| $4.63 | 287,900 | $1,334,128.60 | 0 | 2024-06-10 | Filing | |
| $4.65 | 421,875 | $1,959,609.38 | 0 | 2024-06-10 | Filing | |
| $4.00 | 600,000 | $2,400,000.00 | 600,000 | 2024-06-04 | Filing | |
| $3.75 | 35,000 | $131,250.00 | 0 | 2024-05-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 50,023,485 | $70,533,113 | 0% | |
| 2. | 35,614,200 | $50,216,021 | 0% | |
| 3. | 23,631,876 | $33,320,945 | 0% | |
| 4. | 14,376,311 | $20,270,598 | 0.02% | |
| 5. | 14,152,038 | $19,956,404 | 0% |
News See All
11 Best Single Digit Stocks to Buy According to Hedge Funds
The winning streak of U.S. stocks extended on Wednesday, August 13, 2025, with the S&P 500 and Nasdaq reaching fresh record highs for the second day in a row.
13 Most Promising Penny Stocks Under $5
On August 12, Jill Carey Hall, BofA Securities head of US small and mid-cap strategy, joined 'The Exchange' on CNBC to discuss the outlook for small caps, amidst their underperformance.
Geron Corporation (NASDAQ:GERN) Q2 2025 Earnings Call Transcript
Operator: Hello, and thank you for standing by. My name is Tiffany, and I will be your conference operator today. At this time, I would like to welcome everyone to the Geron Q2 2025 Earnings Call.
Leerink Partners Reiterates a Buy Rating on Geron Corporation (GERN) With a $3 PT
Geron Corporation (NASDAQ:GERN) is one of the best biotech penny stocks to buy right now.
14 Best Biotech Penny Stocks to Buy Right Now
He acknowledged that biotech has been a “super tough sector” either way, as there are hundreds of publicly traded stocks that do not add up to anything in aggregate.
Geron Presents Positive RYTELO Data for LR-MDS at ASCO & EHA, Highlights Efficacy, Myelofibrosis Program Progress
Geron Corporation (NASDAQ:GERN) is one of the best low priced pharma stocks to buy now.
13 Best Low Priced Pharma Stocks to Buy Now
On July 9, Afsaneh Beschloss, RockCreek Group founder & CEO, joined 'Closing Bell Overtime' on CNBC to talk about the latest round of tariff threats.
Leerink Partners Reiterates a Buy Rating on Geron Corporation (GERN)
Geron Corporation (NASDAQ:GERN) is one of the 13 Stocks Under $5 With High Upside Potential.
13 Stocks Under $5 With High Upside Potential
On July 1, Ralph Schlosstein, Evercore chairman emeritus and BlackRock co-founder, appeared on CNBC's 'Closing Bell Overtime' to discuss his outlook for markets heading into the second half of 2025.
Billionaire Hedge Funds
